Abstract 2959: Novel CD38xCD3 bispecific IgM T cell engager, IGM-2644, potently kills multiple myeloma cells though complement and T cell dependent mechanismsKeyu Li, Bruce A. Keyt, Rodnie Rosete et al.|Cancer Research|2023Cited by 2
P815: HIGH VALENCY OF IGM-2644, A CD38XCD3 IGM BISPECIFIC T CELL ENGAGER, DISPLACES DARATUMUMAB BINDING AND INDUCES POTENT MULTIPLE MYELOMA CELL KILLINGKevin C. Hart, Maya F. Kotturi, Daniel Santos et al.|HemaSphere|2023Cited by 0